Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 8/20 | 0.42 |
| ▸ | CA2 | P00918 | 8/20 | 0.42 |
| ▸ | CA9 | Q16790 | 7/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA7 | P43166 | 3/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | CA6 | P23280 | 2/20 | 0.42 |
| ▸ | CA5A | P35218 | 2/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11363997 | 1.00 | THRB (0.50) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL3817506 | 1.00 | THRB (0.50) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL27511841 | 1.00 | THRB (0.50) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL14468772 | 1.00 | THRB (0.50) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL13040134 | 1.00 | THRB (0.50) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL10110913 | 1.00 | THRB (0.50) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL3821892 | 1.00 | — | — | |
| SCHEMBL3822818 | 1.00 | — | — | |
| Water SCHEMBL27849175 | 0.97 | THRB (0.47) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL29575 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 980 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2448895-B1 | CONTINUOUS METHOD FOR THE HYDROGENATION OF AROMATIC COMPOUNDS | AET GROUP (FR) | 2013-05-01 | — | — | EP | claimed |
| US-20120172632-A1 | CONTINUOUS METHOD FOR THE HYDROGENATION OF AROMATIC COMPOUNDS | AET GROUP (FR) | 2012-07-05 | — | — | US | claimed |
| EP-1473335-B1 | INK-JET RECORDING INK AND METHOD OF INK-JET RECORDING | FUJIFILM CORP (JP) | 2009-08-05 | — | — | EP | claimed |
| US-12296304-B2 | Membrane for water filtration | AQUAPORIN A/S (DK) | 2025-05-13 | — | — | US | disclosed |
| EP-4277731-B1 | PROCESS FOR PREPARING A MEMBRANE | AQUAPORIN AS (DK) | 2024-10-09 | — | — | EP | disclosed |
| EP-3747963-B1 | INK SET AND INKJET RECORDING METHOD | FUJIFILM CORP (JP) | 2024-05-29 | — | — | EP | disclosed |
| WO-2024070691-A1 | LAMINATE, IMAGE DISPLAY DEVICE, OPTICAL DEVICE, AND HEAD-MOUNTED DISPLAY | 富士フイルム株式会社 | 2024-04-04 | — | — | WO | disclosed |
| WO-2024070432-A1 | LIQUID CRYSTAL COMPOSITION, OPTICALLY ANISOTROPIC FILM, OPTICAL FILM, POLARIZING PLATE, IMAGE DISPLAY DEVICE AND POLYMERIZABLE COMPOUND | 富士フイルム株式会社 | 2024-04-04 | — | — | WO | disclosed |
| US-20240058768-A1 | MEMBRANE FOR WATER FILTRATION | AQUAPORIN A/S (DK) | 2024-02-22 | — | — | US | disclosed |
| WO-2024024612-A1 | ORIGINAL PLATE FOR FLEXOGRAPHIC PRINTING PLATE AND METHOD FOR MANUFACTURING FLEXOGRAPHIC PRINTING PLATE | 富士フイルム株式会社 | 2024-02-01 | — | — | WO | disclosed |
| US-20240002313-A1 | [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) | 2024-01-04 | — | — | US | disclosed |
| EP-0185506-A2 | Light-sensitive silver halide photographic material | KONICA CORPORATION (JP) | 1986-06-25 | — | — | EP | disclosed |
| EP-0182486-A1 | Silver halide color photographic material | KONICA CORPORATION (JP) | 1986-05-28 | — | — | EP | disclosed |
| EP-0178794-A1 | Silver halide color photographic material | KONICA CORPORATION (JP) | 1986-04-23 | — | — | EP | disclosed |
| EP-0178165-A1 | Silver halide color photographic material | KONICA CORPORATION (JP) | 1986-04-16 | — | — | EP | disclosed |
| EP-0028892-B1 | A HETERONUCLEAR-BRIDGED RHODIUM CLUSTER AND ITS APPLICATION AS CATALYST FOR HYDROFORMYLATION OF OLEFINS | UNION CARBIDE CORPORATION (US) | 1986-03-19 | — | — | EP | disclosed |
| US-4540654-A | Method of forming color image comprising heterocyclic magenta dye-forming coupler | FUJI PHOTO FILM CO., LTD. (JP) | 1985-09-10 | — | — | US | disclosed |
| US-4500630-A | USING AN IMIDAZOLO(1,2-B)PYRAZOLE COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1985-02-19 | — | — | US | disclosed |
| EP-0119741-A2 | Method of producing magenta images in silver halide colour photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1984-09-26 | — | — | EP | disclosed |
| EP-0119860-A2 | Pyrazolo magenta couplers used in silver halide photography | FUJI PHOTO FILM CO., LTD. (JP) | 1984-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002313-A1 | [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | NR2E3, FABP7, RARB | THRB 251/4885TSHR 8/4885MEN1 195/4885 |
| US-20120172632-A1 | CONTINUOUS METHOD FOR THE HYDROGENATION OF AROMATIC COMPOUNDS | HRH4, CRH, HRH2 | THRB 4291/4885TSHR 2704/4885MEN1 4145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.